BiotechTube
Home/DermBiont/Karl Beutner, MD, PhD
KB

Karl Beutner, MD, PhD

Chief Executive Officer, Co-founder

DermBiont

Therapeutic Areas

DermatologyHyperpigmentation Disorders

DermBiont Pipeline

DrugIndicationPhase
SM-030Melasma and other hyperpigmentation disorders of the skinUnknown

Leadership Team at DermBiont

N(
Nichola (Nick) Eliovits
Chief Financial Officer, Co-founder
MN
Max N. Dawson
Chief Operating Officer
ET
Emma Taylor, MD
Advisor, Dermatology
View full DermBiont profile